Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidetoshi Hayashi

Showing results (11-20 of 333) with videos related to

Pageof 34
Sort By:
Biological & Pharmaceutical Bulletin|August 4, 2015
Positive Regulation of Interleukin-2 Expression by a Pseudokinase, Tribbles 1, in Activated T CellsChiharu Miyajima, Yuka Itoh, Yasumichi Inoue, et al.
Biological & Pharmaceutical Bulletin|April 3, 2015
TGF-β decreases the stability of IL-18-induced IFN-γ mRNA through the expression of TGF-β-induced tristetraprolin in KG-1 cellsYasumichi Inoue, Kenji Abe, Kikuo Onozaki, et al.
FEBS Letters|April 23, 2003
C/EBP homologous protein (CHOP) up-regulates IL-6 transcription by trapping negative regulating NF-IL6 isoformTakayuki Hattori, Nobumichi Ohoka, Hidetoshi Hayashi, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 26, 2004
Contribution of the constitutive and inducible degradation of Smad3 by the ubiquitin-proteasome pathway to transforming growth factor-beta signalingYasumichi Inoue, Masatoshi Kitagawa, Kikuo Onozaki, et al.
FEBS Letters|December 18, 2018
TRB1 negatively regulates gluconeogenesis by suppressing the transcriptional activity of FOXO1Kaori Tsuzuki, Yuka Itoh, Yasumichi Inoue, et al.
Drug Design, Development and Therapy|August 13, 2014
Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidenceYosuke Togashi, Hidetoshi Hayashi, Kazuhiko Nakagawa, et al.
Cureus|April 17, 2026
Association Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Antivascular Endothelial Growth Factor-Related Proteinuria in Solid Tumors: A Systematic Review and Meta-AnalysisRyuichi Ohta, Taichi Fujimori, Kaoru Tanaka, et al.
Cureus|March 16, 2026
Efficacy and Safety of Human Epidermal Growth Factor Receptor 2 (HER2) Antibody-Drug Conjugates in Solid Tumors Harboring Non-tyrosine Kinase Domain ERBB2 Mutations: A Systematic ReviewRyuichi Ohta, Taichi Fujimori, Kaoru Tanaka, et al.
Cureus|February 16, 2026
Brain Metastasis After Curative Resection of Non-small Cell Lung Cancer: A Systematic Review and Meta-AnalysisRyuichi Ohta, Kasumi Nishikawa, Kaoru Tanaka, et al.
Journal of Lipid Research|January 12, 2008
TRB3 suppresses adipocyte differentiation by negatively regulating PPARgamma transcriptional activityYu Takahashi, Nobumichi Ohoka, Hidetoshi Hayashi, et al.
Pageof 34

Showing results (11-20 of 333) with videos related to

Sort By:
Pageof 34
Biological & Pharmaceutical Bulletin|August 4, 2015
Positive Regulation of Interleukin-2 Expression by a Pseudokinase, Tribbles 1, in Activated T CellsChiharu Miyajima, Yuka Itoh, Yasumichi Inoue, et al.
Biological & Pharmaceutical Bulletin|April 3, 2015
TGF-β decreases the stability of IL-18-induced IFN-γ mRNA through the expression of TGF-β-induced tristetraprolin in KG-1 cellsYasumichi Inoue, Kenji Abe, Kikuo Onozaki, et al.
FEBS Letters|April 23, 2003
C/EBP homologous protein (CHOP) up-regulates IL-6 transcription by trapping negative regulating NF-IL6 isoformTakayuki Hattori, Nobumichi Ohoka, Hidetoshi Hayashi, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 26, 2004
Contribution of the constitutive and inducible degradation of Smad3 by the ubiquitin-proteasome pathway to transforming growth factor-beta signalingYasumichi Inoue, Masatoshi Kitagawa, Kikuo Onozaki, et al.
FEBS Letters|December 18, 2018
TRB1 negatively regulates gluconeogenesis by suppressing the transcriptional activity of FOXO1Kaori Tsuzuki, Yuka Itoh, Yasumichi Inoue, et al.
Drug Design, Development and Therapy|August 13, 2014
Clinical utility of erlotinib for the treatment of non-small-cell lung cancer in Japanese patients: current evidenceYosuke Togashi, Hidetoshi Hayashi, Kazuhiko Nakagawa, et al.
Cureus|April 17, 2026
Association Between Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Antivascular Endothelial Growth Factor-Related Proteinuria in Solid Tumors: A Systematic Review and Meta-AnalysisRyuichi Ohta, Taichi Fujimori, Kaoru Tanaka, et al.
Cureus|March 16, 2026
Efficacy and Safety of Human Epidermal Growth Factor Receptor 2 (HER2) Antibody-Drug Conjugates in Solid Tumors Harboring Non-tyrosine Kinase Domain ERBB2 Mutations: A Systematic ReviewRyuichi Ohta, Taichi Fujimori, Kaoru Tanaka, et al.
Cureus|February 16, 2026
Brain Metastasis After Curative Resection of Non-small Cell Lung Cancer: A Systematic Review and Meta-AnalysisRyuichi Ohta, Kasumi Nishikawa, Kaoru Tanaka, et al.
Journal of Lipid Research|January 12, 2008
TRB3 suppresses adipocyte differentiation by negatively regulating PPARgamma transcriptional activityYu Takahashi, Nobumichi Ohoka, Hidetoshi Hayashi, et al.
Pageof 34